Arcturus Therapeutics Holdings Inc (ARCT)
26.86
-1.07
(-3.83%)
USD |
NASDAQ |
Apr 24, 15:44
Arcturus Therapeutics Holdings Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.0714 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.2244 |
| September 30, 2022 | 0.4101 |
| June 30, 2022 | 0.3677 |
| March 31, 2022 | 0.3437 |
| December 31, 2021 | 0.2765 |
| September 30, 2021 | 0.2347 |
| June 30, 2021 | 0.2006 |
| March 31, 2021 | 0.1738 |
| December 31, 2020 | 0.0381 |
| September 30, 2020 | 0.0576 |
| June 30, 2020 | 0.1612 |
| March 31, 2020 | 0.8849 |
| December 31, 2019 | 0.5814 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.279 |
| June 30, 2019 | 0.4617 |
| March 31, 2019 | 1.565 |
| December 31, 2018 | 0.7265 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.0843 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
0.8849
Maximum
Mar 2020
0.2509
Average
0.2244
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 429.40M |
| Total Liabilities (Quarterly) | 150.89M |
| Shareholders Equity (Quarterly) | 278.51M |
| Current Ratio | 4.715 |
| Net Debt Paydown Yield | 1.41% |